165 related articles for article (PubMed ID: 37801108)
21. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D
Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911
[TBL] [Abstract][Full Text] [Related]
22. Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease.
Kwon KY; Park S; Kim RO; Lee EJ; Lee M
Sci Rep; 2022 Jul; 12(1):11461. PubMed ID: 35794147
[TBL] [Abstract][Full Text] [Related]
23. Loss of integrity and atrophy in cingulate structural covariance networks in Parkinson's disease.
de Schipper LJ; van der Grond J; Marinus J; Henselmans JML; van Hilten JJ
Neuroimage Clin; 2017; 15():587-593. PubMed ID: 28652971
[TBL] [Abstract][Full Text] [Related]
24. Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease.
Chen H; Wan H; Zhang M; Liu G; Wang X; Wang Z; Ma H; Pan Y; Feng T; Wang Y
Parkinsonism Relat Disord; 2021 Feb; 83():86-92. PubMed ID: 33493785
[TBL] [Abstract][Full Text] [Related]
25. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
[TBL] [Abstract][Full Text] [Related]
26. Predictors of depressive symptoms among spouse caregivers in Parkinson's disease.
Fernandez HH; Tabamo RE; David RR; Friedman JH
Mov Disord; 2001 Nov; 16(6):1123-5. PubMed ID: 11748746
[TBL] [Abstract][Full Text] [Related]
27. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.
Wu G; Jiang Z; Pu Y; Chen S; Wang T; Wang Y; Xu X; Wang S; Jin M; Yao Y; Liu Y; Ke S; Liu S
BMC Neurol; 2022 Jan; 22(1):13. PubMed ID: 34996385
[TBL] [Abstract][Full Text] [Related]
28. The effect of repetitive transcranial magnetic stimulation on cognitive impairment in Parkinson's disease with dementia: Pilot study.
Khedr EM; Mohamed KO; Ali AM; Hasan AM
Restor Neurol Neurosci; 2020; 38(1):55-66. PubMed ID: 31815705
[TBL] [Abstract][Full Text] [Related]
29. Autophagy-independent incorporation of GFP-LC3 into protein aggregates is dependent on its interaction with p62/SQSTM1.
Shvets E; Elazar Z
Autophagy; 2008 Nov; 4(8):1054-6. PubMed ID: 18776740
[TBL] [Abstract][Full Text] [Related]
30. The Association of Olfactory Dysfunction With Depression, Cognition, and Disease Severity in Parkinson's Disease.
Fang TC; Chang MH; Yang CP; Chen YH; Lin CH
Front Neurol; 2021; 12():779712. PubMed ID: 34880827
[No Abstract] [Full Text] [Related]
31. Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer.
Schläfli AM; Adams O; Galván JA; Gugger M; Savic S; Bubendorf L; Schmid RA; Becker KF; Tschan MP; Langer R; Berezowska S
Oncotarget; 2016 Jun; 7(26):39544-39555. PubMed ID: 27250032
[TBL] [Abstract][Full Text] [Related]
32. Early identification of subjective cognitive functional decline among patients with Parkinson's disease: a longitudinal pilot study.
Rosenblum S; Meyer S; Richardson A; Hassin-Baer S
Sci Rep; 2022 Dec; 12(1):22242. PubMed ID: 36564494
[TBL] [Abstract][Full Text] [Related]
33. Is either anosmia or constipation associated with cognitive dysfunction in Parkinson's disease?
Sheng MZ; Fang TC; Chen YH; Chang MH; Yang CP; Lin CH
PLoS One; 2021; 16(6):e0252451. PubMed ID: 34086764
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease.
Cui SS; Du JJ; Fu R; Lin YQ; Huang P; He YC; Gao C; Wang HL; Chen SD
BMC Geriatr; 2017 Nov; 17(1):270. PubMed ID: 29166864
[TBL] [Abstract][Full Text] [Related]
35. Aichi virus 3C protease modulates LC3- and SQSTM1/p62-involved antiviral response.
Kung MH; Lin YS; Chang TH
Theranostics; 2020; 10(20):9200-9213. PubMed ID: 32802187
[No Abstract] [Full Text] [Related]
36. Exploring the association between Cerebral small-vessel diseases and motor symptoms in Parkinson's disease.
Wan Y; Hu W; Gan J; Song L; Wu N; Chen Y; Liu Z
Brain Behav; 2019 Apr; 9(4):e01219. PubMed ID: 30815987
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson's disease.
Zhu J; Shen B; Lu L; Lan W; Pan Y; Zhang L; Dong J; Wang M; Zhang L
J Neurol Sci; 2017 Jan; 372():471-476. PubMed ID: 27823833
[TBL] [Abstract][Full Text] [Related]
38. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal Fluid C-Reactive Protein in Parkinson's Disease: Associations with Motor and Non-motor Symptoms.
Sanjari Moghaddam H; Valitabar Z; Ashraf-Ganjouei A; Mojtahed Zadeh M; Ghazi Sherbaf F; Aarabi MH
Neuromolecular Med; 2018 Sep; 20(3):376-385. PubMed ID: 29980980
[TBL] [Abstract][Full Text] [Related]
40. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
